Syndax Pharmaceuticals Eulerpool Nieuws

Syndax Pharmaceuticals Aandeel Nieuws

Syndax Pharmaceuticals wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Syndax Pharmaceuticals nieuwsberichten verzamelen we hier.

• 23 januari ·

  SeekingAlpha
  Kura Oncology: Sentiment Is Too Negative
• 21 januari ·

  SeekingAlpha
  Syndax Looks Tantalizing, But Looks Can Be Deceptive
• 15 januari ·

  Yahoo
  Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
• 10 januari ·

  Yahoo
  Investing in Syndax Pharmaceuticals (NASDAQ:SNDX) five years ago would have delivered you a 53% gain
• 7 januari ·

  Yahoo
  Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
• 9 december ·

  Yahoo
  Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
• 8 december ·

  Yahoo
  Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
• 4 december ·

  Yahoo
  Why Is Syndax Pharmaceuticals, Inc. (SNDX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
• 27 november ·

  Yahoo
  Syndax Announces Participation at the Citi 2024 Global Healthcare Conference
• 18 november ·

  Yahoo
  Syndax secures FDA OK for new kind of leukemia drug